Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 751 to 760 of 1535

TitleReference numberPublishedLast updated
Dapagliflozin for treating chronic heart failure with reduced ejection fractionTA679
Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitisES35
Metreleptin for treating lipodystrophyHST14
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapyTA673
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)TA674
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)TA675
moorLDLS-BI for burn depth assessmentMIB251
The STAK tool for preventing and treating knee stiffnessMIB252
PROPEL sinus implants for maintaining sinus patency after surgeryMIB253
Trabectedin for the treatment of advanced soft tissue sarcomaTA185

Results per page

  1. 10
  2. 25
  3. 50
  4. All